4//SEC Filing
Reardon Andrew 4
Accession 0002001011-24-000089
CIK 0000886163other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 8:54 PM ET
Size
8.1 KB
Accession
0002001011-24-000089
Insider Transaction Report
Form 4
Reardon Andrew
CLO & Secretary
Transactions
- Exercise/Conversion
Common Stock
2024-09-23$52.27/sh+2,000$104,540→ 24,534 total - Sale
Common Stock
2024-09-23$99.60/sh−2,000$199,201→ 22,534 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-09-23−2,000→ 70,944 totalExercise: $52.27Exp: 2032-08-01→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001950232
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 8:54 PM ET
- Size
- 8.1 KB